|
HS Code |
666693 |
| Product Name | N-(4-Nitrobenzoyl)-Beta-Alanine |
| Cas Number | 3685-40-7 |
| Molecular Formula | C10H10N2O5 |
| Molecular Weight | 238.20 g/mol |
| Appearance | Yellow solid |
| Melting Point | 179-182 °C |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Purity | Typically ≥98% |
| Storage Conditions | Store at room temperature, in a dry place |
| Synonyms | 4-Nitro-N-(3-carboxypropyl)benzamide |
| Inchi Key | ZIZXZRGFXHDZLD-UHFFFAOYSA-N |
As an accredited N-(4-Nitrobenzoyl)-Beta-Alanine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A 25g amber glass bottle with a screw cap, labeled “N-(4-Nitrobenzoyl)-Beta-Alanine” and safety information in bold text. |
| Shipping | **Shipping for N-(4-Nitrobenzoyl)-Beta-Alanine:** This chemical is securely packaged in compliance with safety regulations, protected against moisture and physical damage. It is shipped as a non-hazardous solid at ambient temperature. Appropriate documentation and labelling accompany the shipment, ensuring safe and efficient delivery to laboratories or authorized facilities. |
| Storage | N-(4-Nitrobenzoyl)-Beta-Alanine should be stored in a tightly closed container in a cool, dry, and well-ventilated area away from direct sunlight, heat sources, and incompatible substances such as strong oxidizing or reducing agents. Protect from moisture. Ensure the storage area is equipped for handling chemical spills and is compliant with chemical safety regulations. Store at room temperature, unless otherwise specified. |
Applications of N-(4-Nitrobenzoyl)-Beta-Alanine in Industrial ManufacturingAs a direct manufacturer of N-(4-Nitrobenzoyl)-Beta-Alanine, we supply this compound to specialized sectors that demand strict regulatory compliance, complex formulation integration, and high product consistency. Below, we detail authentic downstream industrial uses where this material forms an essential link in production chains, with deep attention to process and regulatory specifics. 1. Pharmaceutical Intermediate for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)N-(4-Nitrobenzoyl)-Beta-Alanine serves as a targeted intermediate in the synthesis route of select NSAID active ingredients. Its carboxylic and amide functionalities fit specific acylation steps, especially in the construction of key drug scaffolds. Downstream pharmaceutical manufacturers incorporate it in multi-stage reaction sequences, requiring high purity and traceability to ensure that all submissions meet global registrations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Precursor in Specialty Dye ManufacturingThis compound plays a foundation role in producing certain nitro-substituted azo and anthraquinone dyes for technical textiles. Its unique aromatic nitro group enables specific shade tuning in colorfast dye molecules, while the beta-alanine motif supports anchoring groups for better substrate fixation. Dye plants dose it at calculated ratios to achieve precise color properties and standardized solvent fastness. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Building Block for Agrochemical ActivesDownstream pesticide formulators employ this intermediate as part of multicomponent syntheses for certain selective herbicides and insecticides targeting resistant pests. The beta-alanine moiety provides a structural base that, upon further derivatization, enhances specificity for target receptor sites in plant physiology or pest metabolism. Agrochemical manufacturers require accurate dosage and stringent process controls due to downstream environmental and residue compliance checks. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Raw Material for Research Chemical SynthesisCROs (Contract Research Organizations) and fine chemical producers incorporate N-(4-Nitrobenzoyl)-Beta-Alanine into advanced intermediate libraries for medicinal chemistry exploration, structure-activity relationship (SAR) studies, and analytical reference standards. Laboratory-scale and pilot runs demand reproducible delivery, with precise documentation of batch records and compliance to research-grade standards to support preclinical filings. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive N-(4-Nitrobenzoyl)-Beta-Alanine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
N-(4-Nitrobenzoyl)-beta-alanine has steadily gained interest in specialized organic synthesis, especially for researchers and manufacturers who require consistent quality at scale. Years of working with aromatic amino acid derivatives and benzoic acid analogs have shown us that reliability in sourcing and performance can directly influence the outcome of an entire reaction sequence. N-(4-Nitrobenzoyl)-beta-alanine, with its balanced structural reactivity, serves as a key intermediate for those working in pharmaceutical synthesis, advanced material development, and biochemical research.
Our approach to producing N-(4-Nitrobenzoyl)-beta-alanine has developed alongside shifts in methodology and best practices over several decades. Synthesizing compounds that depend on both the nuanced protection of the amino group and the integration of the nitrobenzoyl moiety obliges us to keep quality control at the center of our process. Every batch produced at our facility undergoes multiple purification steps, always confirmed by high-performance liquid chromatography (HPLC). IR, NMR, and mass spectrometry form our indispensable toolkit—if you work with intermediates that react at the scale of a few grams or several hundred kilos, you already know purity requirements leave no room for shortcuts.
Years of shipping N-(4-Nitrobenzoyl)-beta-alanine to pharmaceutical and research partners exposed us to the variation in requirements for particle size, moisture content, and packaging integrity. Our principal product typically meets a specification of >99% purity (by HPLC). Pale yellow to off-white crystalline powder is the standard, though some batches, especially those destined for optoelectronic research groups, require an even finer particle size to aid with dissolution and reaction kinetics.
Analysis always focuses on key markers: melting point falls within a tight range, and residual solvent checks must consistently stay well below internationally accepted thresholds. The presence of residual starting materials, including 4-nitrobenzoic acid or unreacted beta-alanine, remains a major focus during batch release. We have seen that unchecked contaminants can render a whole synthetic campaign useless, particularly when scaling up to pilot or full-plant operations.
Quality in chemical synthesis owes a great deal to understanding the subtle differences in reaction behavior of different analogs. Over long years synthesizing a variety of benzoyl-protected amino acids, we learned that the nitro group’s electron-withdrawing nature on the benzoyl ring consistently delivers greater chemical stability than simple benzoyl or acetyl-protected derivatives. Our N-(4-Nitrobenzoyl)-beta-alanine preserves structural features even under moderately harsh processing conditions. This translates to fewer unexpected side reactions or degradation when introducing the product into multistep syntheses.
We see direct comparison with alternatives in customer feedback. Laboratories using non-nitro-derivatized products often report higher side product formation and difficulties in deprotection steps further down the process chain. For those optimizing yields—especially in catalytic hydrogenations or amidations—the presence of the nitro group on the benzoyl ring can make or break process viability. Our own QC data and those from select partners consistently show higher downstream yields and cleaner reaction profiles with N-(4-Nitrobenzoyl)-beta-alanine.
Most requests for this product come from innovators tackling peptide synthesis or working on fragments for active pharmaceutical ingredient (API) development. Beta-alanine’s flexible role in heterocyclic compound design, especially as a linker, means our product has landed in advanced research labs across university and industrial settings. Peptide chemists appreciate the protection strategy enabled by the nitrobenzoyl group—it’s more robust than many carbamate or simple acyl groups for sequences requiring orthogonal deprotection. The product’s differential reactivity, especially compared with other N-acylated amino acids, enables selective stepwise syntheses without risking backbone degradation or untimely group cleavage.
Work in our own process development lab demonstrated repeatedly that reaction conditions involving strong bases or moderate heat do not decompose N-(4-Nitrobenzoyl)-beta-alanine as readily as they do many N-acetylated or unprotected alanine derivatives. More than a few scale-ups over the years failed not from poor design but from getting stuck with inconsistent intermediates; every time, returning to a rigorously characterized batch of N-(4-Nitrobenzoyl)-beta-alanine got things moving forward again. We keep learning how crucial it is that the protection group remains intact up to the intended step—especially in longer or more sensitive syntheses.
Reliable supply—and the predictability that comes with it—remains central to our operations. We have seen far too many projects slow down only due to a gap in high-purity intermediates. This is particularly true for compounds like N-(4-Nitrobenzoyl)-beta-alanine, where even small shifts in impurity profile can derail a synthesis. The logistic side at our plant pays close attention to humidity control during storage, batch traceability, and rigidly monitored packing lines. Stability data accumulated over the years proved that small lapses in handling lead directly to colour changes and potential byproduct formation, which can compromise the end-use of the substance.
Our core packaging option—a triple-sealed, light-resistant container—did not come from regulatory guidelines alone. Problems with intermediate stability directly inspired this stepwise improvement. Years ago, samples transported in basic PE bags absorbed ambient moisture and air, which led to degradation even under seemingly ‘inert’ conditions. Implementing vacuum-sealed and nitrogen-purged packaging raised product reliability and reduced rejection rates almost to zero.
Scaling up N-(4-nitrobenzoyl)-beta-alanine from multi-gram to multi-kilogram quantities taught us that every step, from reagent selection to pH control during workup, plays a decisive role in product quality. The selection of the nitration agent, order of addition, and purity of solvents all leave lasting effects. Our internally developed crystallization and drying protocols, optimized over hundreds of batches, reduce both residual solvent and fine particle accretion. This means less batch-to-batch variability, cutting both analytical workload and risk.
The experience also exposed us to the challenges of byproduct removal. Trace isomers from incomplete acylation or excessive temperature control, if unchecked, degrade solubility and reactivity down the line. Our technical team’s iterative work led to an efficient washing sequence and recrystallization step, now routine yet essential. At every release, random samples undergo an extra check for trace chlorinated byproducts; we learned the hard way how even minimal contamination here can interfere with catalyst performance for our most demanding clients.
N-(4-nitrobenzoyl)-beta-alanine scores clear wins over plain N-benzoyl and N-acetyl-beta-alanine in stability under oxidative and basic conditions. Customers often ask if they can substitute with a less expensive N-benzoyl analog, but practical trials underline the reasons for sticking to the nitro-derivative. While standard N-benzoyl compounds often lose their integrity during prolonged storage or when exposed to strong acid scavengers, the nitro-modified structure holds its own until it reaches its intended reaction stage.
We have reviewed side-by-side NMR and LC-MS graphs from synthesis teams using various protection groups. Beta-alanine protected with the 4-nitrobenzoyl group introduces a sharper cleavage point both chemically and spectroscopically. This improves the purification of peptides containing beta-alanine, among other amino acids. The added advantage emerges during purification—hydrophobicity and UV activity associated with the nitro group assist in tracking the intermediate’s progress without additional tagging.
Each customer application pushes our technical team to adapt. Some research groups request finer particle sizes for accelerated dissolution in polar aprotic solvents. Others, especially those formulating APIs, insist on residual solvent levels below even the strictest pharmacopoeial demands. Analytical data assembled from hundreds of interactions have pushed us towards even tighter process validation and reporting. It’s not just the product in the jar but the guarantee that each analytical certificate can stand up to third-party scrutiny.
Feedback from scale-up facilities highlighted the importance of homogeneity not only batch to batch but within a single lot, especially as reaction volumes scale into the hundreds of liters. Consistent color, flowability, and ease of weighing—minor issues at small scale—grow into major bottlenecks for large installations. By focusing R&D on reproducibility as much as actual yield targets, we found that customer trust often hinges more on predictable processing behavior than on outlier results.
Certain customers—those integrating the compound into diagnostic kits or preclinical drug candidates—require in-depth impurity profiling, including potential nitro-reduction byproducts. Our response has been to introduce expanded test panels on every production lot destined for regulated market export.
Manufacturing N-(4-nitrobenzoyl)-beta-alanine carries strict safety expectations due to the potent action of nitration agents. Operators handle even minor byproducts, including trace nitroso compounds, with caution. Plant infrastructure emphasizes closed systems and efficient extraction to keep occupational exposure and environmental release in check. Decades of experience show that early investment in proper engineering controls results in fewer reportable incidents and longer equipment life.
Our compliance staff tracks guidance from both regional and international authorities to ensure transport labeling and end-use documentation remains thorough. The product’s handling characteristics—moderate dust propensity, sensitivity to strong reducing agents—have prompted us to update procedural training and offer comprehensive, practical advice to regular customers.
Learning never stops—especially as downstream technology evolves. Recent years saw more demand from fields outside classical peptide chemistry, such as advanced polymer development and specialty pigment formulation. This challenged us to review impurity profiles beyond the usual suspects and forced re-evaluation of solvent use, waste minimization, and analytical method development.
One novel application from a customer’s ink formulation team brought attention to the issue of residual iron contamination. Through root-cause analysis and process revision, our technical team substituted several reactor components and fine-tuned the purification wash sequence. Purity and limited trace metals made a measurable improvement in ink performance under accelerated testing.
Technicians and analysts who have worked with N-(4-nitrobenzoyl)-beta-alanine for years recognize small shifts in spectral data or batch color before analytical results flag any issue. Hands-on familiarity with the compound means our staff often detects subtle changes in crystallization and drying characteristics. In weekly meetings, chemists compare current batches to those produced in previous years, adapting protocols to manage new variables from raw material shifts or solvent sources.
Working with research chemists at partner firms, we routinely field questions about alternative protection strategies, troubleshooting yields, or integration into larger synthetic workflows. Nothing replaces direct observation: we learned that collaborative troubleshooting not only drives up product quality but also lays groundwork for improvements that benefit all customers down the road.
As a manufacturer, we engage directly with the challenges of minimizing impact through efficient feedstock use and maximizing yield per run. Organizing waste streams to recover solvents and reagents for potential reuse became part of our day-to-day operation. Nitroaromatic synthesis brings unmistakable environmental burden—we offset this by investing in abatement facilities and encouraging closed-loop solvent systems where feasible.
Stable process design, with repetitive monitoring, leads to reduced off-spec material and less process waste. Customers frequently inquire about regulatory status and compliance documentation. Offering detailed process transparency reassures stakeholders from purchasing departments to regulatory affairs officers.
Manufacturing N-(4-nitrobenzoyl)-beta-alanine has kept us connected to innovation in pharmaceuticals, diagnostics, and material science. Consistent feedback from those working at the frontiers of synthesis ensures our product meets not just technical requirements, but practical ones shaped by daily reality in laboratories and plants worldwide. Each kilo supplied carries the collective experience of our technical, analytical, and production teams.
As new applications arise, we remain in close contact with researchers and procurement teams, adapting both the scale and scope of our manufacturing to meet emerging needs. Investing in process control, operator training, and detailed analytics forms the backbone of our approach. Producing a quality intermediate means knowing not just the chemistry but also the needs of those who use it.
Going forward, we continue refining product and process, informed by open communication with customers and the practical lessons gained from every production run. This path ensures that N-(4-nitrobenzoyl)-beta-alanine, sourced from a dedicated manufacturing partner, supports both present and future challenges in chemical synthesis.